Search


AI Announcement: Introducing GPT-Rosalind for Life Sciences Research
The global life sciences landscape is rapidly evolving with the integration of advanced artificial intelligence to accelerate drug discovery, genomics, and translational research . OpenAI has introduced a specialized model designed to address the complexity and scale of modern biomedical research workflows. The announcement Introducing GPT-Rosalind for life sciences research , published in April 2026 , presents a purpose-built AI model aimed at supporting scientific reasoning

Sharan Murugan
Apr 203 min read


EMA: Harnessing AI in Medicines Regulation: The Role of Large Language Models (LLMs)
The advancement of Artificial Intelligence (AI) is transforming many industries, and the pharmaceutical and regulatory sectors are no...

Sharan Murugan
Sep 15, 20242 min read
